Skip to main content

Month: December 2025

Okeanis Eco Tankers Corp. – New Financings Update

ATHENS, Greece, Dec. 19, 2025 (GLOBE NEWSWIRE) — Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), announced today it has entered into two new facility agreements, for the financing of the recently acquired newbuilding Suezmax vessels, each under construction at Daehan Shipbuilding Co., Ltd, to be named Nissos Piperi and Nissos Serifopoula respectively, with expected deliveries in January 2026. On December 19, 2025, we entered into a $45.0 million facility agreement, to finance a portion of the acquisition price of the Nissos Piperi, with a prominent Greek bank (the “Nissos Piperi Facility”). The Nissos Piperi Facility contains an interest rate of Term SOFR plus 130 basis points, matures in seven years, and will be repaid in quarterly installments of $0.525 million, together with a balloon installment of...

Continue reading

Galantas Gold Provides Update on Acquisition of RDL Mining Corp. and Brokered Financing

Not for distribution to U.S. newswire services or dissemination in the United States TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQB: GALKF) (“Galantas” or the “Company”) wishes to provide an update with respect to its previously announced acquisition (the “Transaction”) of all of the issued and outstanding shares of RDL Mining Corp. (“RDL”) and its previously announced private placement (the “Offering”) of units of the Company (each, a “Unit”), for $0.08 per Unit (the “Offering Price”), led by Canaccord Genuity Corp. and Haywood Securities Inc. (together, the “Agents”). The Company is working diligently to satisfy remaining closing conditions, including obtaining approval of the Transaction from the TSX Venture Exchange (the “TSXV”), and both the Offering and the Transaction are...

Continue reading

Novartis and US government reach agreement on lowering drug prices in the US

Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricing Additional Novartis medicines will be made available through direct-to-patient platforms in 2026 Company remains committed to investing in markets that value innovation and implement policies that support broad and fast access to medicinesBasel, December 19, 2025 – Novartis, a leading global innovative medicines company, today announced it has reached an agreement with the US government that aims to lower the price of innovative medicines in the US and support continued US investment in manufacturing, and research and development. Novartis has voluntarily agreed to take actions aimed at meeting the US Administration’s drug pricing priorities, including:Launching future medicines with comparable prices across high-income countries Building...

Continue reading

EDF: Changes in the Group’s Executive Committee

 Changes in the Group’s Executive Committee Following the information and consultation procedures with employee representative bodies, and effective 1 January 2026, EDF’s new nuclear activities will be organised around four divisions: • The division of new nuclear project management, responsible for the strategic management of new nuclear programmes, under the responsibility of Xavier Gruz, Group Executive Director. • The division of industrial projects and partnerships, in charge of new nuclear projects management, under the responsibility of Thierry Le Mouroux, Group Executive Director. • The division of nuclear engineering, which provides cross-functional engineering services for both existing facilities and new nuclear projects, under the responsability of Alain Tranzer, Group Executive Director. • International nuclear...

Continue reading

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovationAgreement delivers on President Trump’s four requests, establishing a framework for lower prices for patients in the US and a tariff-free accord for Sanofi Showcases commitment to US manufacturing, innovation, and economic growthParis, December 19, 2025. Sanofi today announced an agreement with President Donald J. Trump’s Administration to help ensure American patients have access to more affordable medicines while also supporting the role of the US in biopharmaceutical manufacturing and innovation. With this agreement, Sanofi confirms its growth strategy to take the lead through breakthrough science and by striving to be a driver of progress and positive impact for the people and communities it serves. The voluntary, confidential...

Continue reading

Dave Cantin Group Advises ZT Automotive in Acquisition of Four Maus Family Automotive Dealerships in Florida Expansion

The acquisition is part of DCG’s ongoing work supporting ZT Automotive’s growth strategyDave Cantin Group Advises ZT Automotive in Acquisition of Four Maus Family Automotive DealershipsDavid Maus (left) and Farrukh Tariq (right), Group Chief Operating Officer for ZT Corporate, shake hands outside one of the four Maus Family Automotive locations in the Tampa Bay area that ZT Automotive acquired. M&A advisory firm Dave Cantin Group represented ZT Automotive as the buy-side advisor in DCG’s ongoing work supporting ZT’s targeted national growth strategy.NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — Dave Cantin Group today announced that it advised ZT Automotive, owned by the Badar Family Office and managed by ZT Corporate, in the acquisition of four Maus Family Automotive locations in the Tampa Bay area: Maus Acura | North...

Continue reading

Morocco Strategic Minerals Closes Private Placement for a Total Amount of $600,000

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES MONTREAL, Dec. 19, 2025 (GLOBE NEWSWIRE) — Morocco Strategic Minerals Corporation. (TSXV: MCC) (“MCC” or the “Corporation”) announce the closing of a non-brokered private placement, raising total gross proceeds of $600,000 through the issuance of 6,000,000 units of the Corporation (“Units”) at a price of $0.10 per Unit (the “Offering”). Each Unit consists in one common share of the Corporation (a “Common Share”) and one half of one Common Share purchase warrant (a “Warrant”). Each whole Warrant entitles its holder to purchase one Common Share at an exercise price of $0.15 per Common Share until December 19, 2027. All securities issued in connection with the Offering are subject to a statutory...

Continue reading

Copper Road Announces Amendments to Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Copper Road Resources Inc. (TSX-V: CRD) (“Copper Road” or the “Company”) announces today that it is amending the terms of its non-brokered private placement offering as previously announced on December 17, 2025. The amended offering (the “Offering”) will consist of the sale of up to: (i) 8,747,500 common share units in the capital of the Company (each, a “Unit”) at a price of $0.04 per Unit for gross proceeds of up to $349,900; and (ii) 13,333,333 flow-through units of the Company (each, a “FT Unit”) at a price of $0.045 per FT Unit for gross proceeds of up $600,000.   Each Unit will consist of one common share of the Company (a “Unit Share”) and one common share purchase...

Continue reading

Canadian GoldCamps Announces Management/Board Changes, Private Placement and Letter of Intent to Acquire Two Québec Gold Projects

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) — Canadian GoldCamps Corp. (CSE: CAMP) (OTC: SMATF) (FSE: A68) (the “Company”) is pleased to announce management and board changes, a non-brokered private placement financing to raise up to $1 million and a binding letter of intent (the “LOI”) in respect of a proposed option agreement to acquire two gold exploration projects in Québec from Stelmine Canada Ltd. (TSXV: STH) (“Stelmine”). MANAGEMENT AND BOARD CHANGES The Company announces that Mr. George Yordanov, P.Geo., has been appointed President and Chief Executive Officer of the Company effective December 18, 2025, replacing Mr. Mike Taylor, who will continue to serve as a director of the Company. Mr. Yordanov is a professional geologist and independent Qualified Person (as defined in National Instrument 43-101 –...

Continue reading

Bombardier Global 8000, World’s Fastest Business Jet, Receives U.S. Federal Aviation Administration (FAA) Certification

The Global 8000(1) is the fastest civilian aircraft since the Concorde with an industry-leading top speed of Mach 0.95 and class-leading range of 8,000 nautical miles (NM) The Global 8000 delivers the lowest cabin altitude in business aviation production of just 2,691 ft. when cruising at 41,000 ft. The Global 8000 received Transport Canada Type Certification on November 5, 2025 and entered into service in December 2025MONTREAL, Dec. 19, 2025 (GLOBE NEWSWIRE) — Bombardier today announced that the Global 8000(1), the world’s fastest business aircraft, received U.S. Federal Aviation Administration (FAA) certification. The FAA certification marks the latest in a series of achievements over the past year that continue to illustrate the exceptional pedigree of this industry-defining ultra-long-range business aircraft – the fastest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.